Best Practices For Compounding Sterile And Non-Sterile Medications With Beyond Use Dates

Compounding medications is a critical aspect of pharmacy practice, ensuring patients receive personalized and effective treatments. Properly managing beyond use dates (BUD) is essential to maintain medication safety and efficacy. This article outlines best practices for compounding sterile and non-sterile medications with a focus on BUD guidelines.

Understanding Beyond Use Dates

Beyond Use Date (BUD) is the date after which a compounded medication should not be used. It is determined based on the stability of the medication, the storage conditions, and the type of preparation. Proper assignment of BUD helps prevent the use of expired or compromised medications.

Best Practices for Compounding Sterile Medications

1. Adhere to USP Guidelines

Follow the United States Pharmacopeia (USP) Chapter 797 for sterile compounding. This includes proper aseptic techniques, environment controls, and documentation to ensure medication sterility and stability.

2. Determine Appropriate BUD

Assign BUD based on stability data, which may be obtained from manufacturer information, scientific literature, or validated stability studies. Typically, sterile preparations have shorter BUDs, often ranging from 24 hours to 14 days, depending on storage conditions.

3. Maintain Aseptic Technique

Ensure all staff are trained in aseptic techniques, including proper hand hygiene, garbing, and environment cleaning. Regular environmental monitoring is also vital to prevent contamination.

Best Practices for Compounding Non-Sterile Medications

1. Use Validated Stability Data

Consult reliable stability resources such as the Trissel’s Stability of Compounded Formulations or peer-reviewed articles to determine BUDs for non-sterile preparations. Always consider the formulation, ingredients, and storage conditions.

2. Proper Labeling and Documentation

Label compounded medications with BUD, storage instructions, and preparation date. Maintain detailed records of compounding procedures, ingredients, and stability data for quality assurance and regulatory compliance.

3. Storage Conditions

Store medications under conditions recommended by stability data. Use appropriate containers to prevent degradation and contamination, and regularly review storage environments for compliance.

Additional Tips for Ensuring Safety and Efficacy

  • Regularly review and update BUDs based on new stability data.
  • Train staff on proper compounding and documentation procedures.
  • Implement quality control measures, including periodic testing and environmental monitoring.
  • Stay informed about changes in regulations and guidelines related to compounding.

By following these best practices, pharmacists can ensure that compounded medications remain safe, effective, and compliant with regulatory standards. Proper management of BUDs is a vital component of quality patient care in pharmacy practice.